Qnity Electronics: Good Business But Valuation Isn't Compelling Here
Dupont De Nemours Inc DD
$137.00
▼ -1.33%
($-1.84)
Index member:
S&P 500
⚡ High Volume
💰 High Dividend
📅 Earnings This Week
Open
$137.95
Prev Close
$138.84
Day Range
$136.58 – $139.40
52W Range
$86.58 – $157.98
Market Cap
$18.75B
Beta
1.06
Div Yield
1.73%
EPS (TTM)
$-0.07
📋 Company Profile
| Industry | Chemicals |
| Sector | Materials |
| Country | US |
| Exchange | NEW YORK STOCK EXCHANGE, INC. |
| Currency | USD |
| IPO Date | 2017-09-01 |
| Shares Out. | 405,060,000 |
| Website | dupont.com/ ↗ |
| Phone | 13022955783 |
| Employees | 15,000 |
| Revenue | $1.68B |
| Gross Profit | $602.0M |
| Net Income | $164.0M |
| Free Cash Flow | $1.03B |
| Total Assets | $21.45B |
| Total Liabilities | $7.21B |
| Equity | $14.24B |
About Dupont De Nemours Inc
DuPont is a diversified global specialty chemicals company created in 2019 as a result of the DowDuPont merger and subsequent separations. Its portfolio includes specialty chemicals and downstream products that serve the healthcare, water, construction, automotive, aerospace, and printing and packaging industries. Healthcare and water will generate the majority of profits.
Dupont De Nemours Inc is a publicly traded company under the ticker symbol DD on the NEW YORK STOCK EXCHANGE, INC., operating in the Chemicals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
26 analysts (2026-07-01)
📰 Latest News for DD
Analysts Estimate Tronox (TROX) to Report a Decline in Earnings: What to Look Out for
DuPont to Report Q2 Earnings: What's in the Offing for the Stock?
4 Chemical Stocks Poised to Outshine Q2 Earnings Estimates
Dow Inc. (DOW) Q2 Earnings and Revenues Beat Estimates
[Latest] Global Implantable Cardiac Fluorine-Free Resins Market Size/Share Worth USD 4.26 Billion by 2035 at a 10.8% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate,SWOT Analysis)
International Paper expands board with two new appointments
